Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR(®) study

BACKGROUND: Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic cell transplantation (HSCT), however, little is known about the impact of prior IFI on survival. METHODS: Patients with pre-transplant IFI (cases; n=825) were compared to controls (n=10,2...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Bone Marrow Transplant
Egile Nagusiak: Maziarz, Richard T., Brazauskas, Ruta, Chen, Min, McLeod, Aleksandra A., Martino, Rodrigo, Wingard, John R., Aljurf, Mahmoud, Battiwalla, Minoo, Dvorak, Christopher C., George, Biju, Guinan, Eva C., Hale, Gregory A., Lazarus, Hillard M., Lee, Jong-Wook, Liesveld, Jane L., Ramanathan, Muthalagu, Reddy, Vijay, Savani, Bipin N., Smith, Franklin O., Strasfeld, Lynne, Taplitz, Randy A., Ustun, Celalettin, Boeckh, Michael J., Gea-Banacloche, Juan, Lindemans, Caroline A., Auletta, Jeffery J., Riches, Marcie L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5358320/
https://ncbi.nlm.nih.gov/pubmed/27991895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.259
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak